CEBPD and pancreatic ductal adenocarcinoma: To further validate the potential tumor-suppressive effects of C/EBPδ in pancreatic ductal adenocarcinoma, we conducted in vitro clonogenic assays with two commonly used pancreatic ductal adenocarcinoma cell lines, PANC-1 and MIA PaCa-2.